CETP inhibitors and cardiovascular disease: Time to think again. - Wikidata - wikimedia - TriplyDB

CETP inhibitors and cardiovascular disease: Time to think again.

CETP inhibitors and cardiovascular disease: Time to think again.

http://www.wikidata.org/entity/Q34109100

about

CETP Inhibition: Past Failures and Future Hopes Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?

P2860

Q26753158-FFEE7517-6063-4E75-A56A-66F41AC7DAF8 Q31053398-BBEBE97A-D8CA-4C85-BFA9-6A0881E319AE Q35847625-D6A89154-0177-4C9E-B61A-EBE1D8723F32

P2860

CETP inhibitors and cardiovascular disease: Time to think again.

http://www.wikidata.org/entity/Q34109100

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CETP inhibitors and cardiovascular disease: Time to think again.

@ast

CETP inhibitors and cardiovascular disease: Time to think again.

@en

CETP inhibitors and cardiovascular disease: Time to think again.

@nl

type

label

CETP inhibitors and cardiovascular disease: Time to think again.

@ast

CETP inhibitors and cardiovascular disease: Time to think again.

@en

CETP inhibitors and cardiovascular disease: Time to think again.

@nl

prefLabel

CETP inhibitors and cardiovascular disease: Time to think again.

@ast

CETP inhibitors and cardiovascular disease: Time to think again.

@en

CETP inhibitors and cardiovascular disease: Time to think again.

@nl

P1433

Q34109100-D6C8C9C1-637E-4042-A255-4CB0C16753D7

P1476

Q34109100-19055790-05D5-4D1E-8030-E02E640621DC

P2093

Q34109100-35313344-FAD8-4E3D-A55F-C8992788BEF1

P2860

Q34109100-0260023C-4EAB-4424-BF98-CC119D6A23E2

Q34109100-046643D4-3DCF-482A-B817-6DD42F8F5A35

Q34109100-06D7DD18-732C-4CD6-BF2F-0B2C9B7839F9

Q34109100-1198D842-7F6A-49F4-9A3C-0E30EBD86E3A

Q34109100-140018F6-528C-44FB-8FAC-22CE43C5CB4B

Q34109100-193D5284-0880-4FA7-B143-CF90A01A9034

Q34109100-1A3E79FE-5A91-4821-817F-3486E6055E8C

Q34109100-1A4F3BFB-D4D3-4FC8-A0C9-2EB5A9AFBCA2

Q34109100-2640C11F-B55A-4D45-B1C3-3AB197963772

Q34109100-4116F4C0-D565-4638-9CD3-685DA2BDDB06

P304

Q34109100-ECC04283-8CD8-45B7-AE85-E691D3B97646

P31

Q34109100-2B4B25E9-8268-4689-A4D4-A619C722807C

P356

Q34109100-170E7F6B-E41E-4ACD-A840-A17C84C158B9

P478

Q34109100-365338CE-6925-4E2C-B428-821A37D831E5

P577

Q34109100-9C35CD0E-0EC2-4AF0-8A08-77EF058D9783

P5875

Q34109100-B86DC81D-A768-4995-9F88-A3F87843BC29

P698

Q34109100-E2E2BDCE-9A83-4796-92D8-A05B5B3393B0

P921

Q34109100-B07F3A44-C84B-4392-A027-1EB4B848AAEB

P932

Q34109100-BAA8C61A-A8C4-470A-98FE-B322FDB17128

P356

F1000RESEARCH.4396.1

P1433

P1476

CETP inhibitors and cardiovascular disease: Time to think again.

@en

P2093

Norman E Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for genome-wide association studies

A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study

Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Effects of torcetrapib in patients at high risk for coronary events

Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.

Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.

Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

P304

124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.4396.1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265343956

http://www.w3.org/2001/XMLSchema#string

P698

25187879

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4149245

http://www.w3.org/2001/XMLSchema#string